# Phase 1 open-label, multiple ascending dose trial of AGEN1884, an anti-CTLA-4 monoclonal antibody, in advanced solid malignancies.

**Type:** Papers  
**Canonical URL:** https://scholariq.org/papers/phase-1-open-label-multiple-ascending-dose-trial-of-agen1884-an-anti-ctla-4/

## Facts

| Field | Value |
| --- | --- |
| Author Names | Breelyn A. Wilky,Priya Kumthekar,Robert Wesolowski,Jimmy J. Hwang,Jeffrey J. Raizer,Carleen Gentry,Ainsley Ross,Elise E. Drouin,Nicholas S. Wilson,Olga Shebanova,John M. Goldberg,Jennifer S. Buell,Robert B. Stein,Jean-Marie Cuillerot |
| Citations | 1 |
| DOI | 10.1200/jco.2017.35.15_suppl.3075 |
| Fields | Immunology and Microbiology,Medicine |
| Open Access | false |
| OA Status | closed |
| OpenAlex ID | https://openalex.org/W2776752536 |
| Type | conference-abstract |
| Year | 2017 |

## Paper authors

- [Ainsley Ross](https://scholariq.org/researchers/ainsley-ross/)

## Paper journal

- [Journal of Clinical Oncology](https://scholariq.org/journals/journal-of-clinical-oncology/)

## Paper primary topic

- [Cancer Immunotherapy and Biomarkers](https://scholariq.org/topics/cancer-immunotherapy-and-biomarkers/)

## Paper topics

- [Cancer Immunotherapy and Biomarkers](https://scholariq.org/topics/cancer-immunotherapy-and-biomarkers/)
- [CAR-T cell therapy research](https://scholariq.org/topics/car-t-cell-therapy-research/)
- [Biosimilars and Bioanalytical Methods](https://scholariq.org/topics/biosimilars-and-bioanalytical-methods/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.